Table 2 Inhibition percent of rat paw edema after administration of newly synthesized compounds

0.49 ± 0.032^a

30.22 ± 1.27^a

33.85 ± 1.19^a

36.21 ± 0.93^a

41.10 ± 3.98^a

0.48 ± 0.027^ab

21.72 ± 0.79^b

22.79 ± 1.07^d

24.79 ± 0.49^c

28.41 ± 1.30^c

0.47 ± 0.04^ab

31.98 ± 9.35^a

29.93 ± 1.43^b

34.16 ± 0.61^b

41.15 ± 0.750^a

0.46 ± 0.03^b

18.91 ± 1.19^bc

20.07 ± 1.43^e

21.96 ± 1.25^d

27.38 ± 1.68^c

0.49 ± 0.01^ab

21.43 ± 0.96^b

26.27 ± 49^e

33.13 ± 2.64^b

37.15 ± 0.69^b

0.49 ± 0.01^a

11.62 ± 1.24^de

14.61 ± 1.81^g

18.41 ± 1^e

19.48 ± 0.89^e

0.48 ± 0.01^ab

15.41 ± 0.83^cd

18.83 ± 0.75^ef

24.19 ± 1.59^c

28.59 ± 2.26^c

0.50 ± 0.02^a

9.61 ± 1.12^e

12.28 ± 1.38^h

17.19 ± 1.26^e

18.51 ± 2.26^e

0.49 ± 0.01^a

13.75 ± 1.15^de

17.52 ± 1.13^f

20.43 ± 0.65^d

22.39 ± 1.16^d